# Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)

> **NCT07717216** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Weifang Medical University** · enrollment: 314 (estimated)

## Conditions studied

- Stroke, Acute
- Neuroprotection
- Normobaric Hyperoxia
- Endovascular Treatment

## Interventions

- **DRUG:** Oxygen (Normobaric Hyperoxia)
- **DRUG:** Sham Normobaric Hyperoxia
- **PROCEDURE:** Endovascular Therapy

## Key facts

- **NCT ID:** NCT07717216
- **Lead sponsor:** Weifang Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2029-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 314 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717216, "Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07717216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*